Home / Knowledge Centre /

Biocatalysis is a Key Technology for Successful Chiral Synthesis at Almac

Dr Tom Moody, Head of Biocatalysis and Isotope Chemistry and Dr Stefan Mix, Biocatalysis Team Leader at Almac describe the latest biocatalytic technologies developed by the company and how they
are assiting in API development.
The technology is used to support its broader chemistry offerings for the synthesis of advanced chiral intermediates and APIs for pharmaceutical and biotech customers.

View Resource

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies